CN106377593A - Traditional Chinese pharmaceutical composition for treating subacute eczema - Google Patents
Traditional Chinese pharmaceutical composition for treating subacute eczema Download PDFInfo
- Publication number
- CN106377593A CN106377593A CN201611084385.XA CN201611084385A CN106377593A CN 106377593 A CN106377593 A CN 106377593A CN 201611084385 A CN201611084385 A CN 201611084385A CN 106377593 A CN106377593 A CN 106377593A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- pharmaceutical composition
- chinese pharmaceutical
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/342—Adenophora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of traditional Chinese medicines and in particular relates to a traditional Chinese pharmaceutical composition for treating subacute eczema. The traditional Chinese pharmaceutical composition is prepared from the following raw materials in parts by weight: 5 to 10 parts of fructus gardenia, 5 to 8 parts of liquorice root, 5 to 10 parts of folium mori, 5 to 10 parts of chrysanthemum flower, 10 to 20 parts of lotus leaf, 10 to 20 parts of cortex magnoliae officinalis, 2 to 8 parts of cortex moutan, 5 to 10 parts of the root of straight ladybell and 1 to 5 parts of the stem pith of tetrapanax papyriferus. According to the traditional Chinese pharmaceutical composition disclosed by the invention, a monarch drug is the fructus gardenia; ministerial drugs comprise the cortex magnoliae officinalis and the cortex moutan; adjuvant drugs comprise the root of straight ladybell and the stem pith of tetrapanax papyriferus; messenger drugs comprise the chrysanthemum flower, the folium mori, the liquorice root and the lotus leaf. The traditional Chinese pharmaceutical composition has the efficacy of quickly controlling skin inflammation, relieving itching, and recovering or enhancing the improvement on skin barrier functions by delaying or reducing attack, thereby improving the life quality of a patient.
Description
Technical field
The present invention relates to technical field of Chinese medicine, particularly a kind of Chinese medicine composition treating subacute eczema.
Background technology
With the continuous rising of Global Temperature, the climatic change characteristics in four seasons spring, summer, autumn and winter are more and more inconspicuous, the short time
Arise that the replacement of multiple weathers, the sickness rate of damp-heat disease increases year by year.Damp-heat disease main inducing includes following several：1、
Weather is sultry, is recently affected by muggy weather and suffers from summer damp and hot patient's showed increased, and wherein, uncomfortable in chest, dizzy, appetite is not
Situations such as good, scorching, perspiration is a lot of or has no sweating are particularly common.2nd, body metabolism is vigorous the autumn in summer, and energy expenditure is larger, but by
Sultry in weather, perspire not smooth, result in moisture accumulation.If being negligent of nursing one's health, it is easily caused damp-heat disease.3rd, moist rainy, special
After being not the Summer Solstice, much area all enters rainy season, if body constitution is not good, the gas of extraneous turbid damp will take advantage of a weak point in opponent's defence and
Enter.If insufficiency of the spleen add trouble to again, the gas of turbid damp will gather in vivo, is particularly deposited in internal organs and meridians.4th, empty
Adjust cold air, when outdoor temperature raises, people are accustomed to hiding to indoor " sighing " cold air although the hardship from heat is perspired less, but hold
Easily it is led to a series of disease.In addition, in air conditioner surroundings, people does not perspire, also can originally should by diaphoresis leak wet
Turbid stay in the body, thus cause disease.
Cause because of damp-heat disease disease include eczema, cough flu, parotitiss, tinea pedis, gastritis, infantile diarrhea, choke every, urinate
Frequently, aphtha, pharyngitis, night sweat etc. more than 30 are planted.The fast development of agricultural modernization and storage technique is so that personnel can take the photograph simultaneously
Take more vegetables in improper season and fruit, people's recipe selection face is wider, diet is abundanter, but has been further exacerbated by damp-heat disease
Diffusion and induction rate.
Content of the invention
Present invention solves the technical problem that be to provide a kind of compatibility rationally, one kind of effect is significant treat subacute eczema
Chinese medicine composition.
The technical solution adopted for the present invention to solve the technical problems is：
A kind of Chinese medicine composition treating subacute eczema, is formulated by following raw material：SHANZHIZI 5-10 part, Radix Glycyrrhizae
5-8 part, Folium Mori 5-10 part, Flos Chrysanthemi 5-10 part, lotus leaves 10-20 part, Cortex Magnoliae Officinalis 10-20 part, Cortex Moutan 2-8 part, Radix Adenophorae (Radix Glehniae) 5-10 part, white
Medulla Tetrapanacis 1-5 part.
It is formulated by following raw material：6 parts of SHANZHIZI, 6 parts of Radix Glycyrrhizae, 6 parts of Folium Mori, 6 parts of Flos Chrysanthemi, lotus leaves 15
Part, 15 parts of Cortex Magnoliae Officinalis, 6 parts of Cortex Moutan, 6 parts of Radix Adenophorae (Radix Glehniae), 4 parts of white Medulla Tetrapanacis.
Beneficial effects of the present invention are：
Eczema, is equivalent to " eczema " in the traditional Chinese medical science, " eczema ", and person says " ecthyma " to be such as born in shank, is born in the fossa cubitalis or muscular prominence fossa part then
Claim " atopic eczema ", be born in scrotum and be " eczema of scrotum ", it is no less than 10 kinds of.Primary disease is fallen ill, and substantially has three reasons, and one is to report
Assign intolerant to wind, wet, hot visitor are caused by skin, one is because eating and drinking without temperance, and surfeit is pungent, the product of fish raw meat wind symptom, or wound of being addicted to drink
And taste, dysfunction of the spleen in transportation, damp and hot interior life, feel rheumatism pathogenic heat, inside and outside combined pathogens, biphase knot of fighting again, excessive invade skin and send out;Or ferritic is empty
Weak, the spleen being blocked by dampness, failure of skin and muscle to be nourished, or damp and hot accumulate long, consume impairment of YIN blood, blood-deficiency and wind-dry, caused by failure of skin and muscle to be nourished.
The SHANZHIZI heat clearing away of the present invention, pathogenic fire purging, removing heat from blood, Radix Glycyrrhizae invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, Folium Mori are dredged
Dissipate wind-heat, suppressing the hyperactive liver removing heat from blood, Flos Chrysanthemi dispelling wind and heat pathogens, heat-clearing and toxic substances removing, lotus leaves affix one's name to clearly dampness removing, and Cortex Magnoliae Officinalis circulation of qi promoting disappears
Long-pending, eliminating dampness except full, lowering the adverse QI to relieve asthma, Cortex Moutan clearing away heat and cooling blood, Radix Adenophorae (Radix Glehniae) clearing lung and nourishing yin, white Medulla Tetrapanacis heat clearing away, diuretic.This
In invention monarch drug be SHANZHIZI, ministerial drug be Cortex Magnoliae Officinalis, Cortex Moutan, adjuvant drug be Radix Adenophorae (Radix Glehniae), white Medulla Tetrapanacis, make medicine be Flos Chrysanthemi, Folium Mori, Radix Glycyrrhizae, lotus
Floral leaf.Quick control scytitiss, alleviate prurituss, by delaying and mitigating outbreak, recover or strengthen skin barrier function and improve,
Thus improving the quality of life of patient.Subacute eczema clinical diagnosises difficulty is huge, once missing treatment period it is easy to cause
The irreversible damage of skin, by originally can the effective control state of an illness.
Specific embodiment
A kind of Chinese medicine composition treating subacute eczema, is formulated by following raw material：SHANZHIZI 5-10 part,
Radix Glycyrrhizae 5-8 part, Folium Mori 5-10 part, Flos Chrysanthemi 5-10 part, lotus leaves 10-20 part, Cortex Magnoliae Officinalis 10-20 part, Cortex Moutan 2-8 part, Radix Adenophorae (Radix Glehniae) 5-10
Part, white Medulla Tetrapanacis 1-5 part.
It is formulated by following raw material：6 parts of SHANZHIZI, 6 parts of Radix Glycyrrhizae, 6 parts of Folium Mori, 6 parts of Flos Chrysanthemi, lotus leaves 15
Part, 15 parts of Cortex Magnoliae Officinalis, 6 parts of Cortex Moutan, 6 parts of Radix Adenophorae (Radix Glehniae), 4 parts of white Medulla Tetrapanacis.
Embodiment 1
A kind of Chinese medicine composition treating subacute eczema, is formulated by following raw material：5 parts of SHANZHIZI, Radix Glycyrrhizae 5
Part, 5 parts of Folium Mori, 5 parts of Flos Chrysanthemi, 10 parts of lotus leaves, 10 parts of Cortex Magnoliae Officinalis, 2 parts of Cortex Moutan, 5 parts of Radix Adenophorae (Radix Glehniae), 1 part of white Medulla Tetrapanacis.
Embodiment 2
A kind of Chinese medicine composition treating subacute eczema, is formulated by following raw material：10 parts of SHANZHIZI, Radix Glycyrrhizae 8
Part, 10 parts of Folium Mori, 10 parts of Flos Chrysanthemi, 20 parts of lotus leaves, 20 parts of Cortex Magnoliae Officinalis, 8 parts of Cortex Moutan, 10 parts of Radix Adenophorae (Radix Glehniae), 5 parts of white Medulla Tetrapanacis.
Embodiment 3
A kind of Chinese medicine composition treating subacute eczema, is formulated by following raw material：6 parts of SHANZHIZI, Radix Glycyrrhizae 6
Part, 6 parts of Folium Mori, 6 parts of Flos Chrysanthemi, 15 parts of lotus leaves, 15 parts of Cortex Magnoliae Officinalis, 6 parts of Cortex Moutan, 6 parts of Radix Adenophorae (Radix Glehniae), 4 parts of white Medulla Tetrapanacis.
Contrast test 1
By the medicine of above-described embodiment 1-3, it is prepared into traditional decoction or the watered pill.Sufferer is divided into three groups, every group of 10 people, make respectively
With embodiment 1-3 prescription therapeutic, through the daily clothes of long-term experiment decoction, take 300-500 mL, recovery from illness in ten days about；The watered pill
Daily two clothes, take 20-50 part, recovery from illness in ten to two ten days.Above-mentioned three kinds of embodiments all play curative effect to disease.
Contrast test 2
For verifying the clinical and practicality of the present invention, 120 sufferer experiments are carried out, wherein men and women half and half, from embodiment 3
Decoction, take 7 days.Effective and cure according to 1, cure：Above-mentioned disease is wholly absent.2nd, effective：Above-mentioned disease takes a turn for the better
Or mitigate.3rd, invalid：Above-mentioned disease does not take a turn for the better completely or mitigates.Cure 105, effective 15, invalid 0.Cure rate is high
Reach 87.5%, cure and obvious effective rate is up to 100%.
Claims (2)
1. a kind of Chinese medicine composition treating subacute eczema is it is characterised in that be formulated by following raw material：Fructus Gardeniae
Sub- 5-10 part, Radix Glycyrrhizae 5-8 part, Folium Mori 5-10 part, Flos Chrysanthemi 5-10 part, lotus leaves 10-20 part, Cortex Magnoliae Officinalis 10-20 part, Cortex Moutan 2-8 part,
Radix Adenophorae (Radix Glehniae) 5-10 part, white Medulla Tetrapanacis 1-5 part.
2. a kind of Chinese medicine composition treating subacute eczema according to claim 1 is it is characterised in that by following weight
Part preparation of raw material forms：6 parts of SHANZHIZI, 6 parts of Radix Glycyrrhizae, 6 parts of Folium Mori, 6 parts of Flos Chrysanthemi, 15 parts of lotus leaves, 15 parts of Cortex Magnoliae Officinalis, 6 parts of Cortex Moutan,
6 parts of Radix Adenophorae (Radix Glehniae), 4 parts of white Medulla Tetrapanacis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611084385.XA CN106377593A (en) | 2016-11-30 | 2016-11-30 | Traditional Chinese pharmaceutical composition for treating subacute eczema |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611084385.XA CN106377593A (en) | 2016-11-30 | 2016-11-30 | Traditional Chinese pharmaceutical composition for treating subacute eczema |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106377593A true CN106377593A (en) | 2017-02-08 |
Family
ID=57959852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611084385.XA Withdrawn CN106377593A (en) | 2016-11-30 | 2016-11-30 | Traditional Chinese pharmaceutical composition for treating subacute eczema |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106377593A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108815053A (en) * | 2018-08-23 | 2018-11-16 | 青岛康盛生物科技有限公司 | A kind of clearing damp rash gel and preparation method thereof |
-
2016
- 2016-11-30 CN CN201611084385.XA patent/CN106377593A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108815053A (en) * | 2018-08-23 | 2018-11-16 | 青岛康盛生物科技有限公司 | A kind of clearing damp rash gel and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102451356A (en) | Chinese medicinal herb cold tea | |
| CN105309718A (en) | Brown sugar ginger tea capable of eliminating dampness | |
| CN102225156B (en) | Plaster for external use for treating dermatophytosis | |
| CN103798476B (en) | A kind of health protection tea and preparation method thereof | |
| CN103110706B (en) | Traditional Chinese medicine composition for treating rhinitis and preparation method thereof | |
| CN106377593A (en) | Traditional Chinese pharmaceutical composition for treating subacute eczema | |
| CN102755623A (en) | Medicine for treating acute gastroenteritis and preparation method thereof | |
| CN106728152A (en) | A kind of Chinese medicine composition for treating acute eczema | |
| CN106421023A (en) | Traditional Chinese medicinal composition for treating recurrent eczema | |
| CN106701450A (en) | Hibiscus flower wine with heat clearing and cough relieving functions and preparation method of hibiscus flower wine | |
| CN106389542A (en) | Traditional Chinese medicine composition for treating chronic eczema | |
| CN106491766A (en) | A kind of Chinese medicine composition for treating eczema | |
| CN106390003A (en) | Traditional Chinese medicine composition for treating acute parotitis | |
| CN106620204A (en) | Traditional Chinese medicine composition for treating acute pharyngitis | |
| CN106421619A (en) | Traditional Chinese medicine composition for treating parotitis | |
| CN108938835A (en) | " huge bucket dipping " improves outer bathing packet of precious jade medicine of nettle rash and preparation method thereof | |
| CN106540130A (en) | A kind of Chinese medicine composition for treating night sweat | |
| CN107361186A (en) | A kind of sunstroke prevention tea | |
| CN107661452A (en) | Prevent and treat Chinese herbal feed additive of pig anemopyretic cold and preparation method thereof | |
| CN106511880A (en) | Traditional Chinese medicine composition for treating chronic parotitis | |
| CN106390087A (en) | Traditional Chinese medicine composition for treating scale-keratinization beriberi | |
| CN106333033A (en) | Chinese herbal medicine tea bag and manufacturing method thereof | |
| CN106729037A (en) | A kind of Chinese medicine composition for treating heavy night sweat | |
| CN106390085A (en) | Traditional Chinese medicine composition for treating chronic enteritis | |
| CN105770454A (en) | Traditional Chinese medicine preparation for nursing infectious respiratory tract inflammation and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170208 |